IndustrialsElectronic and Electrical Equipment
  • Price (USD)332.37
  • Today's Change1.39 / 0.42%
  • Shares traded134.28k
  • 1 Year change-5.36%
  • Beta0.7987
Data delayed at least 15 minutes, as of Jul 01 2022 18:23 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Waters Corporation is a specialty measurement company that primarily designs, manufactures, sells and services high performance liquid chromatography (HPLC) ultra-performance liquid chromatography and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. The Company’s segments include Waters and TA. The Waters operating segment is designing, manufacturing, selling and servicing liquid chromatography (LC) and MS instruments, columns and other precision chemistry consumables that can be integrated and used along with other analytical instruments. The TA operating segment designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments. The Company's LC and LC-MS instruments are utilized in a range of industries to detect, identify, monitor and measure the chemical, physical and biological composition of materials, and to purify compounds.

  • Revenue in USD (TTM)2.87bn
  • Net income in USD704.55m
  • Incorporated1991
  • Employees7.80k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Integra Lifesciences Holdings Corp1.56bn156.58m4.49bn3.80k29.422.7816.222.881.841.8418.3019.430.42061.736.55410,
MKS Instruments, Inc.3.00bn572.10m5.71bn6.00k10.001.898.401.9110.2710.2753.7954.440.69182.796.63499,616.7013.2011.3014.5612.5846.4445.9319.0815.913.7230.410.212712.1426.5917.8957.5039.3835.304.81
Cognex Corporation1.08bn277.37m7.39bn2.26k27.465.4424.846.841.551.556.037.820.56233.057.52478,723.1014.4315.1715.9016.4072.0574.2725.6728.482.75--0.0044.8727.8814.3958.8614.223.8210.68
Bruker Corporation2.46bn282.00m9.37bn7.77k33.939.2125.093.811.851.8516.136.810.74651.706.65316,574.408.657.6812.0610.5050.3347.9411.599.571.7223.830.539512.9621.668.4675.6012.5319.920.00
Bio-Rad Laboratories, Inc.2.90bn-101.13m14.70bn7.90k--1.46459.825.08-4.88-4.8896.34340.100.20462.076.64366,558.30-0.714524.42-0.747726.3656.8055.45-3.4983.244.160.68240.10520.0014.817.1611.55177.08-3.10--
PerkinElmer, Inc.5.02bn740.94m17.94bn16.70k22.952.5015.623.576.206.2041.7556.970.42513.875.23300,534.306.286.637.127.7054.7052.3114.7614.321.439.160.40386.5533.9519.0929.5534.3225.800.00
Fortive Corp5.37bn650.40m19.49bn18.00k29.992.0418.273.631.811.8014.9726.680.35174.486.11298,444.404.375.235.246.4157.4755.0012.4315.080.73958.780.28114.0613.38-0.4635-58.09-4.77-14.6014.87
Waters Corporation2.87bn704.55m19.94bn7.80k28.9353.2923.806.9511.4411.4446.566.210.91733.354.95367,679.6022.5416.2029.4819.4458.5758.4824.5724.161.7524.440.79390.0017.785.1532.845.8512.12--
Avantor Inc7.55bn534.40m20.94bn13.50k36.325.6622.302.770.85620.856212.137.140.64065.945.93559,325.905.08--5.74--34.1732.517.932.421.184.810.6115--15.5260.60876.92--30.02--
Keysight Technologies Inc5.14bn1.02bn24.81bn14.50k24.946.5619.754.835.535.5327.7921.010.66552.346.95359,510.5013.247.6815.989.2563.9658.1719.9011.732.2616.640.32170.0017.0611.1142.5821.6913.84--
AMETEK, Inc.5.79bn1.04bn25.37bn18.50k24.543.6618.814.384.484.4824.8530.020.51345.166.78312,935.009.258.8410.5310.2034.4836.2018.0216.730.884116.900.267916.8822.177.6313.4814.0911.8317.32
Mettler-Toledo International Inc.3.81bn793.32m26.05bn15.60k33.73308.0828.796.8434.0634.06163.623.731.194.156.39244,316.1024.8521.4335.6130.0758.2358.0020.8118.720.79422.860.95680.0020.518.1927.5814.88-2.79--
Illumina, Inc.4.66bn700.00m28.96bn9.80k40.212.6629.146.224.584.5830.2369.390.38753.508.12475,102.005.8310.936.5812.9668.8168.8115.0323.161.54--0.13770.0039.7313.5416.1610.49-5.15--
Data as of Jul 01 2022. Currency figures normalised to Waters Corp's reporting currency: US Dollar USD

Institutional shareholders

47.12%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 20226.44m10.70%
Fundsmith LLPas of 31 Mar 20224.51m7.49%
BlackRock Fund Advisorsas of 31 Mar 20224.21m7.00%
Walter Scott & Partners Ltd.as of 31 Mar 20223.50m5.81%
SSgA Funds Management, Inc.as of 31 Mar 20222.74m4.54%
Massachusetts Financial Services Co.as of 31 Mar 20222.46m4.09%
Wellington Management Co. LLPas of 31 Mar 20221.50m2.50%
Geode Capital Management LLCas of 31 Mar 20221.16m1.93%
Champlain Investment Partners LLCas of 31 Mar 20221.01m1.67%
Northern Trust Investments, Inc.(Investment Management)as of 31 Mar 2022840.36k1.40%
More ▼
Data from 31 Mar 2022 - 31 Mar 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.